What is everolimus?

EverolimusBelongs to a class of drugs called kinase inhibitors and is used to prevent organ transplant rejection and treat certain benign (non-cancerous) and cancerous tumors.

Everolimus is an inhibitor of a kinase called mammalian target of rapamycin (mTOR) , which plays an important role in regulating how cells in the body reproduce, form new blood vessels and utilize nutrients. In people with cancer, everolimus slows tumor growth by reducing blood flow to the tumors. Everolimus blocks the activity of mTOR by binding to and forming a complex with a protein called FKBP-12.

For people who have had a liver or kidney transplant, everolimus works as an immunosuppressant to prevent your body from attacking or rejecting the transplanted organ. Everolimus works by preventing a type of white blood cell called lymphocyte from activating and multiplying. These cells normally help the body fight off invading organisms, but after an organ transplant, immune system cells are not expected to attack or reject the new organ. Everolimus inhibits antigen and interleukin stimulation of lymphocytes (IL-2 and IL-15).

Before taking everolimus, tell your doctor, including if you have or have had kidney disease and have or have had liver disease. Suffering from diabetes or high blood sugar, Infection, Having hepatitis B, Having skin cancer or it runs in the family. If you have this condition, you should not take everolimus to prevent transplant rejection. There are officially listed generic drugs in India, IndiaGlenmarkPharmaceutical retail price5mg10 tablets 900yuan, 10mg10 tablets 1500yuan. IndiaciplaPharmaceutical retail price5mg10tablets860yuan, 10mg10tablets1300yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.